David W. Kaufman, ScD
Professor
Boston University School of Public Health
Dept of Epidemiology

ScD, Harvard University
MS, Harvard University



David W. Kaufman is Professor of Epidemiology at the Boston University School of Public Health and Associate Director of the Slone Epidemiology Center. He obtained his M.S. and Sc.D. in Epidemiology from Harvard School of Public Health. In 1975 he joined the newly created Drug Epidemiology Unit (now the Slone Epidemiology Center ) as a Research Associate. His early career as an epidemiologist at the DEU was primarily spent in studies of drugs and other factors in relation to cancer, heart disease, and various other conditions. Together with Drs. Slone, Shapiro, and Lynn Rosenberg, he participated in the development of Case-Control Surveillance. In the 1980s, Dr. Kaufman was co-investigator of the International Agranulocytosis and Aplastic Anemia Study, a pioneering effort in the evaluation of these extremely rare but often drug-induced blood dyscrasias that was conducted in seven countries with several hundred cases enrolled. He has directed studies of aplastic anemia in Thailand and the United States. The Thai study is the largest epidemiological investigation of aplastic anemia that has been conducted, with over 500 cases and 2200 controls. Dr. Kaufman pursued his interest in rare drug induced diseases as principal investigator of an international study of Stevens-Johnson syndrome and toxic epidermal necrolysis conducted in four countries in Europe, and a study of anaphylaxis conducted in Spain, Hungary, India, and Sweden. Other major activities have included an international study of analgesics in relation to upper gastrointestinal bleeding and the National Analgesic Nephropathy Study, a multicenter study of end stage renal disease patients in three regions of the U.S. Dr. Kaufman worked closely with Allen Mitchell in the implementation of the Slone Survey, a U.S. population-based survey of medication use. He was principal investigator of a recently completed study that documented an inverse relationship between Oxalobacter formigenes, an oxalate metabolizing bacterium found in the colons of about 40% of the normal population, and calcium oxalate kidney stones. Dr. Kaufman was the PI of the Patient Registries at Slone: Myeloma and MDS, a recent nationwide effort that followed patients with the two diseases through the course of their illness. He was Assistant Director of the Slone Epidemiology Unit from 1986 to 1997, and has been Associate Director since 1998.

Director
Boston University School of Public Health
Slone Epidemiology Center




Behavioral Surveillance of Acetaminophen Users and Non-Users
03/16/2010 - 12/31/2017 (PI)
McNeill Consumer Healthcare

Privigen use and haemolytic anaemia in adults and children and the Privigen safety profile in children with CIDP - an observational hospital-based cohort study in the US (Study IGPRO10_5003)
10/22/2014 - 12/31/2014 (PI)
CSL Behring LLC

Sanofi: Pilot study to explore using a physician-based social networking site for enrollment of patients with myeloproliferate neoplasms in quality of life research
09/01/2012 - 02/28/2013 (PI)
Sanofi-Aventis, U.S., LLC

Onyx: Pilot Study to explore using a physician-based social networking site for enrollment of patients with myeloproliferative neoplasms in quality of life research
09/01/2012 - 02/28/2013 (PI)
Onyx Pharmaceuticals, Inc.

Incyte: Pilot study to explore using a physician-based social networking site for enrollment of patients with myeloproliferative neoplasms in quality of life research
09/01/2012 - 02/28/2013 (PI)
Incyte Corporation

Protocol for Development for a Feasibility Study of Thromboembolic Events & Mortality among Users of Beriplex
08/01/2012 - 10/31/2012 (PI)
CSL Behring LLC

Oxalobacter Formigenes and Other Factors In Urolithiasis
08/01/2003 - 07/31/2007 (PI)
NIH/National Diabetes & Digestive & Kidney Diseases
5 R01 DK62270 03

Herbal Medicine Use in Minority Populations in the U.S.
04/01/2004 - 03/31/2007 (PI)
NIH/Center for Complementary & Alternative Medicine
5 R21 AT02239 02

Cardiovascular Disease Risks of Meloxicam and other NSAIDS
04/06/2005 - 03/31/2006 (PI)
Boehringer Ingelheim Pharmaceuticals, Inc. (Germany)

Consulting Agreement-Pilot Study of Upper GI Bleeding in Japan
07/01/2002 - 06/30/2005 (PI)
Pharmacia Corp

Showing 10 of 16 results. Show All Results



Yr Title Project-Sub Proj Pubs
2005 Herbal Medicine Use in Minority Populations in the US 5R21AT002239-02 1
2005 Oxalobacter Formigenes and Other Factors in Urolithiasis 5R01DK062270-03 4
2004 Herbal Medicine Use in Minority Populations in the US 1R21AT002239-01 1
2004 Oxalobacter Formigenes and Other Factors in Urolithiasis 5R01DK062270-02 4
2003 Oxalobacter Formigenes and Other Factors in Urolithiasis 1R01DK062270-01A1 4
2000 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 5R01HL035068-09 14
1999 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 5R01HL035068-08 14
1998 APLASTIC ANEMIA EPIDEMIOLOGY--INCIDENCE AND CASE CONTROL 2R01HL035068-07A1 14
1995 DATA FROM TWO STUDIES OF BLOOD DYSCRASIAS 5R03HL052351-02
1995 ANALGESIC AND NSAID USE AND GASTROINTESTINAL BLEEDING 5R01DK036997-08 6
Showing 10 of 24 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Borgatta L, Kaufman D, Kelly JP, Babaian D, Banks M. Applications for Research Concerning Fetal or Placental Tissue and Expected Institutional Review Board Responses. J Empir Res Hum Res Ethics. 2017 Jul; 12(3):150-160. PMID: 28535711.
  2. Ernst FR, Pocoski J, Cutter G, Kaufman DW, Pleimes D. Analysis of Diagnoses Associated with Multiple Sclerosis-Related In-Hospital Mortality Using the Premier Hospital Database. Int J MS Care. 2016 May-Jun; 18(3):154-61. PMID: 27252603; DOI: 10.7224/1537-2073.2014-109;.
  3. Shiffman S, Rohay JM, Battista D, Kelly JP, Malone MK, Weinstein RB, Kaufman DW. Patterns of acetaminophen medication use associated with exceeding the recommended maximum daily dose. Pharmacoepidemiol Drug Saf. 2015 Sep; 24(9):915-21. PMID: 26149538; DOI: 10.1002/pds.3830;.
  4. Goodin DS, Corwin M, Kaufman D, Golub H, Reshef S, Rametta MJ, Knappertz V, Cutter G, Pleimes D. Causes of death among commercially insured multiple sclerosis patients in the United States. PLoS One. 2014; 9(8):e105207.View Related Profiles. PMID: 25144226; PMCID: PMC4140735; DOI: 10.1371/journal.pone.0105207;.
  5. Kaufman DW, Reshef S, Golub HL, Peucker M, Corwin MJ, Goodin DS, Knappertz V, Pleimes D, Cutter G. Survival in commercially insured multiple sclerosis patients and comparator subjects in the U.S. Mult Scler Relat Disord. 2014 May; 3(3):364-71.View Related Profiles. PMID: 25876474; DOI: 10.1016/j.msard.2013.12.003;.
  6. Kaufman DW, Kelly JP, Rohay JM, Malone MK, Weinstein RB, Shiffman S. Prevalence and correlates of exceeding the labeled maximum dose of acetaminophen among adults in a U.S.-based internet survey. Pharmacoepidemiol Drug Saf. 2012 Dec; 21(12):1280-8. PMID: 23001694; DOI: 10.1002/pds.3350;.
  7. Hall SA, Chiu GR, Kaufman DW, Wittert GA, Link CL, McKinlay JB. Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey. BJU Int. 2012 Jun; 109(11):1676-84. PMID: 21951754; PMCID: PMC3249016; DOI: 10.1111/j.1464-410X.2011.10593.x;.
  8. Kelly JP, Kaufman DW, Dunant A, Mockenhaupt M, Roujeau JC. Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole. J Am Acad Dermatol. 2011 Jun; 64(6):1193-4. PMID: 21571188; DOI: 10.1016/j.jaad.2009.08.036;.
  9. Prihartono N, Kriebel D, Woskie S, Thetkhathuek A, Sripaung N, Padungtod C, Kaufman D. Risk of aplastic anemia and pesticide and other chemical exposures. Asia Pac J Public Health. 2011 May; 23(3):369-77. PMID: 21490113; DOI: 10.1177/1010539511403605;.
  10. Kelly JP, Curhan GC, Cave DR, Anderson TE, Kaufman DW. Factors related to colonization with Oxalobacter formigenes in U.S. adults. J Endourol. 2011 Apr; 25(4):673-9. PMID: 21381959; PMCID: PMC3071521; DOI: 10.1089/end.2010.0462;.
Showing 10 of 130 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 122 publications over 35 distinct years, with a maximum of 9 publications in 1980

YearPublications
19809
19813
19825
19834
19845
19857
19863
19876
19884
19896
19903
19914
19921
19933
19941
19953
19964
19976
19994
20002
20012
20023
20031
20054
20065
20086
20095
20102
20115
20121
20131
20141
20151
20161
20171
Contact for Mentoring:


72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Kaufman's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department